SEC Comment Letter for Bionano Genomics, Inc. (BNGO) (CIK 0001411690) (BNGO) — May 20, 2020

Bionano Genomics, Inc. (BNGO) (CIK 0001411690)
Date: May 20, 2020 · CIK: 0001411690 · Accession: 0000000000-20-004494

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38613

Date

May 19, 2020

Author

R. Erik Holmlin, Ph.D.

Form

UPLOAD

Company

Bionano Genomics, Inc. (BNGO) (CIK 0001411690)

Letter

United States securities and exchange commission logo May 19, 2020 R. Erik Holmlin, Ph.D. Chief Executive Officer Bionano Genomics, Inc 9540 Towne Centre Drive, Suite 100 San Diego, CA 92121 Re:Bionano Genomics, Inc Preliminary Proxy Statement on Schedule 14A Filed May 13, 2020 File No. 001-38613 Dear Mr. Holmlin: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: James Pennington, Esq.

Show Raw Text

United States securities and exchange commission logo
May 19, 2020
R. Erik Holmlin, Ph.D.
Chief Executive Officer
Bionano Genomics, Inc
9540 Towne Centre Drive, Suite 100
San Diego, CA 92121
Re:Bionano Genomics, Inc
Preliminary Proxy Statement on Schedule 14A
Filed May 13, 2020
File No. 001-38613
Dear Mr. Holmlin:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       James Pennington, Esq.

SecProbe.io